Table 4 Results of meta-regression analysis for predicting the presence or absence of endometrial carcinoma with variables: use or non-use of hormone replacement therapy (HRT); technique of ultrasound measurement (single or double layer); and population enrolment (consecutive or other).
From: Meta-DiSc: a software for meta-analysis of test accuracy data
Meta-Regression(Inverse Variance weights) (1) | ||||
|---|---|---|---|---|
Var. | Coeff. | p-value | RDOR | [95%CI] |
Cte. | 0,857 | 0,1571 | ---- | ---- |
S | 0,263 | 0,0208 | ---- | ---- |
Layers | 0,709 | 0,0610 | 2,03 | (0,97;4,27) |
Consecutive | 0,206 | 0,7398 | 1,23 | (0,35;4,26) |
HRT | 0,324 | 0,4152 | 1,38 | (0,63;3,06) |
Meta-Regression(Inverse Variance weights) (2) | ||||
Var. | Coeff. | p-value | RDOR | [95%CI] |
Cte. | 0,849 | 0,1565 | ---- | ---- |
S | 0,253 | 0,0194 | ---- | ---- |
Layers | 0,739 | 0,0424 | 2,09 | (1,03;4,27) |
HRT | 0,320 | 0,4152 | 1,38 | (0,63;3,02) |
Meta-Regression(Inverse Variance weights) (3) | ||||
Var. | Coeff. | p-value | RDOR | [95%CI] |
Cte. | 0,959 | 0,0999 | ---- | ---- |
S | 0,258 | 0,0166 | ---- | ---- |
Layers | 0,712 | 0,0482 | 2,04 | (1,01;4,13) |